News related to Taxotere (Docetaxel) and/or conditions it is approved for
Sanofi-Aventis Pharma S.A. Withdraws Its Application For An Extension Ofindication For Taxotere And Docetaxel Winthrop (docetaxel)
Source: Breast Cancer News From Medical News Today [2008.11.18]
The European Medicines Agency (EMEA) has been formally notified by Sanofi-Aventis Pharma S.A. of its decision to withdraw its application for an extension of indication for the centrally authorised medicines Taxotere (docetaxel) 20 mg/0.5 ml and 80 mg/2 ml, concentrate and solvent for solution for infusion and Docetaxel Winthrop (docetaxel) 20 mg/0.5 ml and 80 mg/2 ml, concentrate and solvent for solution for infusion.
FDA Safety Labeling Changes: Taxotere, Twinject, Paxil, and Others
Source: Medscape Primary Care Headlines [2004.08.18]
The FDA has approved changes to safety labeling for docetaxel (Taxotere), epinephrine auto-injector (Twinject), and several antidepressants.
Medscape Medical News
Yael Waknine
June 2004
Source: Medscape Pharmacotherapy Headlines [2004.06.11]
FDA approved Vidaza as an orphan drug for the treatment of myelodysplastic syndrome. Additional oncology drug approvals include new indications for Gemzar, Iressa, and Taxotere.
Medscape Pharmacists
|
